Outcomes Study: Inpatient Behavioral Health Utilization of Continuous Glucose Monitoring in a Pharmacist-Led Diabetes Management Program

All Posts

Outcomes Study: Inpatient Behavioral Health Utilization of Continuous Glucose Monitoring in a Pharmacist-Led Diabetes Management Program

Members of our team had the opportunity to present a new poster abstract, "Inpatient Behavioral Health Utilization of Continuous Glucose Monitoring in a Pharmacist-Led Diabetes Management Program", at the ASHP 2024 Midyear Meeting held December 8 - 12, 2024.

 

Authors:

Alyssa B. Bouley, PharmD, CPS Montana State Hospital | Richard C. Daniels, PharmD, BCPS, CPS Montana State Hospital

 

Background:

  • Patients with severe mental illness are at significantly increased risk for developing type II diabetes mellitus and metabolic syndrome.
  • Inadequate management of type II diabetes and metabolic syndrome can result in costly and life-altering macrovascular complications.
  • Continuous glucose monitoring (CGM) has been shown to decrease hypoglycemia rates and increase the time spent with the target glycemic range compared to traditional blood glucose monitoring.¹
  • Due to an established diabetes management program, pharmacists at an inpatient behavioral health facility are well positioned to create a workflow aimed at transitioning eligible patients to CGM.

 

Objectives:

  • The objective of this study is to describe the development of a workflow used to implement CGM in a pharmacist-led diabetes management program in an inpatient behavioral health hospital.

Read about the team's findings by downloading the outcomes study below.

 

 

Submit your contact information below to receive insights from our team of pharmacy solutions experts.